Article metrics
PDF
Other content recommended for you
- Are patients with amyotrophic lateral sclerosis at risk of a therapeutic misconception?
- Understanding the ‘therapeutic misconception’ from the research participant’s perspective
- Vulnerability, therapeutic misconception and informed consent: is there a need for special treatment of pregnant women in fetus-regarding clinical trials?
- Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues
- Advances in molecular pathology, diagnosis, and treatment of amyotrophic lateral sclerosis
- Informed consent for early-phase clinical trials: therapeutic misestimation, unrealistic optimism and appreciation
- Cerebrospinal fluid phosphorylated neurofilament heavy chain and chitotriosidase in primary lateral sclerosis
- Occupational exposure and amyotrophic lateral sclerosis in a prospective cohort
- Does the index-to-ring finger length ratio (2D:4D) differ in amyotrophic lateral sclerosis (ALS)? Results from an international online case–control study
- Understanding people’s ‘unrealistic optimism’ about clinical research participation